Evaluation of AI-derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial.
L, Z., Y, R., R, T., Y, B., NY, Y., & Q, C. (2026). Evaluation of AI-derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial.. Medical physics. https://doi.org/10.1002/mp.70621
L Z, Y R, R T, Y B, NY Y, Q C. Evaluation of AI-derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial.. Medical physics. 2026; doi: 10.1002/mp.70621
L Z, Y R, R T, et al. Evaluation of AI-derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial.[J]. Medical physics. 2026. DOI: 10.1002/mp.70621.
@article{l2026,
author = {Zhu L and Rong Y and Tao R and Bai Y and Yu NY and Chen Q},
title = {Evaluation of AI-derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial.},
journal = {Medical physics},
year = {2026},
doi = {10.1002/mp.70621},
note = {PMID: 42545172},
}
TY - JOUR AU - Zhu L AU - Rong Y AU - Tao R AU - Bai Y AU - Yu NY AU - Chen Q TI - Evaluation of AI-derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial. T2 - Medical physics PY - 2026 DO - 10.1002/mp.70621 AN - PMID:42545172 ER -
BACKGROUND: While the radiation dose to left anterior descending (LAD) artery is associated with overall survival (OS) in NSCLC patients, manual segmentation is labor-intensive. Several auto-segmentation models were developed on average 4DCT with promising geometric agreement, yet their feasibility in clinical outcome analysis on lung CT remains unclear. PURPOSE: This study evaluates whether automated LAD segmentation can reproduce, at the group level, the established dose-survival association in a multi-institutional clinical trial dataset. METHODS: Three deep learning-based auto-segmentation (DLAS) models for automatic segmentation of the LAD coronary artery were applied to 460 patients from the NRG Oncology/RTOG 0617 dataset. Kaplan-Meier curves and Cox proportional hazard ratio (HR) were calculated using each model's segmentation. The LAD V15 Gy was used to stratify patients into high-and low-risk groups, and the cut-off values were determined by minimizing mean absolute error (MAE) between DLAS-derived and manual OS curves. RESULTS: All three models demonstrated significantly different OS curves between the high risk and low risk groups (p < 0.05). The HR was 1.40 (95% CI: 1.02-1.93; p = 0.0381; MAE = 7.1%), 1.32 (95% CI: 1.03-1.68; p = 0.0258; MAE = 9.6%), and 1.37 (95% CI: 1.03-1.84; p = 0.0331; MAE = 7.9%) for the three models using a common V15 Gy ≥ 10% cut-off. After optimizing the cut-off, one model aligned well with what was derived from manual segmentation (MAE = 4.3%). CONCLUSION: Among the evaluated models, one DL model showed the strongest performance of survival groups separation and achieved group-level overall survival stratification comparable to that previously reported using manual contours in the multi-institutional cohort. Further validation with paired manual contours and pre-specified cutoffs is warranted.